BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37746770)

  • 21. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
    Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
    Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barrett's esophagus and Barrett's carcinoma.
    von Rahden BH; Stein HJ; Siewert JR
    Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.
    Spechler SJ
    Med Clin North Am; 2002 Nov; 86(6):1423-45, vii. PubMed ID: 12510459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Barrett's esophagus.
    Mayrand S
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():98B-102B. PubMed ID: 9347188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
    Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
    Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy.
    Salem SB; Kushner Y; Marcus V; Mayrand S; Fallone CA; Barkun AN
    Can J Gastroenterol; 2009 Feb; 23(2):99-104. PubMed ID: 19214284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus.
    Attwood SE; DeMeester TR; Bremner CG; Barlow AP; Hinder RA
    Surgery; 1989 Oct; 106(4):764-70. PubMed ID: 2799652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
    Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
    Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's Esophagus - State of the Art.
    Tanţău M; Laszlo M; Tanţău A
    Chirurgia (Bucur); 2018; 113(1):46-60. PubMed ID: 29509531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Barrett's esophagus free of dysplasia.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's esophagus.
    Spechler SJ
    Semin Gastrointest Dis; 1996 Apr; 7(2):51-60. PubMed ID: 8705259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
    De Backer AI; De Schepper AM; Pelckmans P
    Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations and complications of gastroesophageal reflux disease (GERD).
    Malfertheiner P; Hallerbäck B
    Int J Clin Pract; 2005 Mar; 59(3):346-55. PubMed ID: 15857335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.